[
    {
        "source": {
            "primary_name": "Inflammatory bowel disease (IBD)",
            "candidates": [
                "Inflammatory Bowel Disease",
                "Inflammatory bowel disease (IBD)",
                "IBD",
                "Crohn's Disease",
                "Ulcerative Colitis",
                "Chronic Inflammatory Bowel Disease"
            ],
            "entity_name": "Inflammatory bowel disease (IBD)",
            "type": "Disease",
            "description": "A group of inflammatory conditions of the colon and small intestine.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Infliximab",
            "candidates": [
                "Infliximab",
                "Remicade",
                "Chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-\u03b1)"
            ],
            "entity_name": "Infliximab",
            "type": "Drug",
            "description": "A TNF antagonist used in the treatment of inflammatory bowel disease.",
            "is_ambiguous": false
        },
        "relationship": "treated with",
        "description": "IBD patients are treated with the TNF antagonist infliximab."
    },
    {
        "source": {
            "primary_name": "Infliximab",
            "candidates": [
                "Infliximab",
                "Remicade",
                "Chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-\u03b1)"
            ],
            "entity_name": "Infliximab",
            "type": "Drug",
            "description": "A TNF antagonist used in the treatment of inflammatory bowel disease.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Arachidonate 15-Lipoxygenase",
            "candidates": [
                "Arachidonate 15-Lipoxygenase",
                "ALOX15",
                "Lipoxygenase type 15",
                "15-Lipoxygenase",
                "15-LOX"
            ],
            "entity_name": "ALOX15",
            "type": "Gene",
            "description": "A gene involved in the metabolism of lipids and inflammatory responses.",
            "is_ambiguous": false
        },
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of ALOX15 in the study."
    },
    {
        "source": {
            "primary_name": "Infliximab",
            "candidates": [
                "Infliximab",
                "Remicade",
                "Chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-\u03b1)"
            ],
            "entity_name": "Infliximab",
            "type": "Drug",
            "description": "A TNF antagonist used in the treatment of inflammatory bowel disease.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Fc Fragment of IgE Receptor 1 Alpha Chain",
            "candidates": [
                "Fc Fragment of IgE Receptor 1 Alpha Chain",
                "FCER1A",
                "High-affinity immunoglobulin E receptor alpha chain",
                "CD23"
            ],
            "entity_name": "FCER1A",
            "type": "Gene",
            "description": "A gene that encodes the high-affinity IgE receptor component, involved in allergic responses.",
            "is_ambiguous": false
        },
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of FCER1A in the study."
    },
    {
        "source": {
            "primary_name": "Infliximab",
            "candidates": [
                "Infliximab",
                "Remicade",
                "Chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-\u03b1)"
            ],
            "entity_name": "Infliximab",
            "type": "Drug",
            "description": "A TNF antagonist used in the treatment of inflammatory bowel disease.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Oligodendrocyte Transcription Factor 2",
            "candidates": [
                "Oligodendrocyte Transcription Factor 2",
                "OLIG2",
                "OLIG2 Transcription Factor",
                "Oligodendrocyte-specific transcription factor 2"
            ],
            "entity_name": "OLIG2",
            "type": "Gene",
            "description": "A gene that plays a role in oligodendrocyte development and function.",
            "is_ambiguous": false
        },
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of OLIG2 in the study."
    }
]